TECH vs VYNE · P/E 65, rev $1.22B vs rev $501.0K
Bio-Techne Corp (TECH) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the TECH and VYNE stock pages for the full models.
Not investment advice.